Novo Nordisk Aktie
59,12
EUR
-1,76
EUR
-2,89
%
59,42
EUR
-0,58
EUR
-0,97
%
Werbung
Novo Nordisk Aktie Analyse
| 29.04.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 29.04.22 | Novo Nordisk Outperform | Bernstein Research | |
| 29.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 27.04.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 21.04.22 | Novo Nordisk Outperform | Bernstein Research | |
| 19.04.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 14.04.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
|
Werbung
|
|||
| 12.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.04.22 | Novo Nordisk Neutral | Credit Suisse Group | |
| 29.03.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 22.03.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 16.03.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.03.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.03.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 04.03.22 | Novo Nordisk Hold | Deutsche Bank AG | |
| 28.02.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.02.22 | Novo Nordisk Overweight | Barclays Capital | |
| 08.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 07.02.22 | Novo Nordisk Hold | Deutsche Bank AG | |
| 03.02.22 | Novo Nordisk Neutral | UBS AG | |
| 03.02.22 | Novo Nordisk Outperform | Bernstein Research | |
| 03.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 03.02.22 | Novo Nordisk Hold | Deutsche Bank AG | |
| 03.02.22 | Novo Nordisk Neutral | Credit Suisse Group | |
| 02.02.22 | Novo Nordisk Outperform | Bernstein Research | |
| 02.02.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 31.01.22 | Novo Nordisk Overweight | Barclays Capital | |
| 26.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 26.01.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 24.01.22 | Novo Nordisk Outperform | Bernstein Research | |
| 06.01.22 | Novo Nordisk Hold | Deutsche Bank AG | |
| 06.01.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 04.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 04.01.22 | Novo Nordisk Outperform | Bernstein Research | |
| 21.12.21 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 21.12.21 | Novo Nordisk Overweight | Barclays Capital | |
| 20.12.21 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 07.12.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.12.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 29.11.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 26.11.21 | Novo Nordisk Neutral | UBS AG | |
| 26.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.11.21 | Novo Nordisk Outperform | Bernstein Research | |
| 22.11.21 | Novo Nordisk Overweight | Barclays Capital | |
| 19.11.21 | Novo Nordisk Neutral | UBS AG | |
Werbung
Werbung